- Tailored radiotherapy: Dose and schedule
- HER2 targeted therapy: What, when and for how long?
- Can we avoid over or undertreatment of DCIS?
- When is the optimal time to integrate palliative care?
- Who is the right candidate for neoadjuvant therapy?
- The changing landscape of breast imaging for screening and diagnosis
- Rethinking trial design
- Can screening and prevention be integrated and personalized?
- When can targeted therapies replace chemotherapy?
- Optimizing choices for mastectomy and reconstruction
- Should oligometastatic disease be treated with curative intent?
- The extent/intensity of endocrine therapy: Balancing efficacy with quality of life
Skip to content
